HU169554B - - Google Patents

Info

Publication number
HU169554B
HU169554B HUIE681A HUIE000681A HU169554B HU 169554 B HU169554 B HU 169554B HU IE681 A HUIE681 A HU IE681A HU IE000681 A HUIE000681 A HU IE000681A HU 169554 B HU169554 B HU 169554B
Authority
HU
Hungary
Application number
HUIE681A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU169554B publication Critical patent/HU169554B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUIE681A 1974-04-22 1975-03-27 HU169554B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/463,092 US3935196A (en) 1974-04-22 1974-04-22 Useful pro-drug forms of theophylline

Publications (1)

Publication Number Publication Date
HU169554B true HU169554B (en:Method) 1976-12-28

Family

ID=23838827

Family Applications (1)

Application Number Title Priority Date Filing Date
HUIE681A HU169554B (en:Method) 1974-04-22 1975-03-27

Country Status (20)

Country Link
US (1) US3935196A (en:Method)
AR (1) AR205739A1 (en:Method)
AT (1) AT336040B (en:Method)
BE (1) BE827327A (en:Method)
DE (1) DE2513693A1 (en:Method)
DK (1) DK135167B (en:Method)
ES (1) ES436781A1 (en:Method)
FI (1) FI750939A7 (en:Method)
FR (1) FR2267784A1 (en:Method)
GB (1) GB1490432A (en:Method)
GT (1) GT197536542A (en:Method)
HU (1) HU169554B (en:Method)
IL (1) IL46957A0 (en:Method)
NL (1) NL7503728A (en:Method)
NO (1) NO751063L (en:Method)
OA (1) OA04909A (en:Method)
PH (1) PH10721A (en:Method)
PL (1) PL93798B1 (en:Method)
SE (1) SE7503607L (en:Method)
ZA (1) ZA75753B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002756A (en) * 1974-04-22 1977-01-11 Interx Research Corporation Useful pro-drug forms of theophylline
US4060617A (en) * 1976-04-01 1977-11-29 Johann A. Wulfing Esters of the ophyllinylacetic acid
US4085214A (en) * 1976-10-18 1978-04-18 Interx Research Corporation Stable pro-drug forms of theophylline
ES517622A0 (es) * 1982-11-23 1983-12-16 Faes Procedimiento de preparacion de un nuevo espirodecano.
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729643A (en) * 1956-01-03 J-disubstmjied and i

Also Published As

Publication number Publication date
GT197536542A (es) 1976-09-21
DE2513693A1 (de) 1975-11-13
GB1490432A (en) 1977-11-02
ES436781A1 (es) 1977-04-16
AR205739A1 (es) 1976-05-31
DK135167C (en:Method) 1977-08-15
NL7503728A (nl) 1975-10-24
FI750939A7 (en:Method) 1975-10-23
SE7503607L (sv) 1975-10-23
DK133375A (en:Method) 1975-10-23
PH10721A (en) 1977-08-25
ATA235975A (de) 1976-08-15
FR2267784A1 (en:Method) 1975-11-14
AT336040B (de) 1977-04-12
PL93798B1 (en:Method) 1977-06-30
US3935196A (en) 1976-01-27
NO751063L (en:Method) 1975-10-23
OA04909A (fr) 1980-10-31
DK135167B (da) 1977-03-14
AU7958375A (en) 1976-09-30
IL46957A0 (en) 1975-05-22
ZA75753B (en) 1976-03-31
BE827327A (fr) 1975-09-29

Similar Documents

Publication Publication Date Title
FI750939A7 (en:Method)
DK281775A (en:Method)
DK63675A (en:Method)
AR199134A1 (en:Method)
DK140296C (en:Method)
AU495870B2 (en:Method)
CS172146B1 (en:Method)
AU7253374A (en:Method)
AU7470174A (en:Method)
AU7478474A (en:Method)
FI164274A7 (en:Method)
CH594688A5 (en:Method)
BG19872A1 (en:Method)
AU479624A (en:Method)
AU490706A (en:Method)
AU482294A (en:Method)
BG19682A1 (en:Method)
BG20143A1 (en:Method)
CH564966A5 (en:Method)
BG19713A1 (en:Method)
AU480308A (en:Method)
AU480465A (en:Method)
AU479408A (en:Method)
AU480143A (en:Method)
CH591287A5 (en:Method)